BCL2L11 and cystadenocarcinoma: Conversely, silencing the short isoform of UCA1 elevated miR-27a-5p and BIM expressions, leading to enhanced sensitization of established DDP-resistant serous cystadenocarcinoma OAW42 cells to DDP [65].